Search

Operating profit grew faster than revenue, but finance costs absorbed about half of that result as the company expanded its fixed assets.

MeCure Industries has opened a Series 8 commercial paper offer of up to ₦14 billion under its ₦40 billion programme, priced at a 21% gross implied yield as the drugmaker funds working capital ahead of expanding production investment.